Ailene Thiel, CEO RD Therapeutics, was one of the tight circle of delegates invited to attend this important summit. We are dedicated to playing our part in the #100DaysMission (4/4)
In a true spirit of international collaboration, Ailene Thiel discussed the QuickStripTM oral thin-film technology with governments, associations, academic institutions, healthcare providers and pharmaceutical companies to ensure we are prepared for the next pandemic. (1/4)
Industry has stepped forward to commit its expertise and resources to achieving the #100DaysMission, including by investing in R&D to combat epidemic and pandemic diseases and reducing manufacturing complexity🌍🔬
Find out more👉https://t.co/ZtDyVWabaK
the current pandemic and the next “Disease X” by making safe, effective vaccines within 100 days of the World Health Organization’s (WHO) identification of a new pathogen. (3/4)
Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member #DOSE
https://t.co/Tnbn78f7cY
Pleased to have worked with #tilray and #aphria to develop this new #medical#cannabis product.
We are confident that patients will be happy with the #QuickStrip delivery system.
We are excited to announce that our medical subsidiary, Aphria, has launched medical cannabis oral strips in THC and CBD-rich varieties. Learn more https://t.co/L5IiQ4SD9g $TLRY
We are excited to announce that our medical subsidiary, Aphria, has launched medical cannabis oral strips in THC and CBD-rich varieties. Learn more https://t.co/L5IiQ4SD9g $TLRY
As we set our sights on global expansion and scale through strategic alliances and proprietary commercialization opportunities, we are pleased to welcome our advisory board of industry leading experts to support our growth.
https://t.co/1WXYJLy0uQ
Rapid Dose Therapeutics and McMaster University Provide Update on COVID-19 Vaccine Research Collaboration with Orally Dissolvable QuickStrip™ Technology
https://t.co/XAsVpUKifp
Rapid Dose Therapeutics-Branded Cannabis Products in Retail Locations Across Canada Via Master Distribution Agreement with Namaste Technologies Subsidiary CannMart @Namaste_Tech
https://t.co/SP1Jy9jDQT
Imagine if, instead of a needle, you got vaccinated by letting a strip dissolve in your mouth. Researchers in #HamOnt & #BurlOn are working on it
https://t.co/7QxiP00c2P
Today I joined @RapidDose & @McMasterU as they announced the next stage of their research into an oral #COVID19 vaccine. This research could be a game changer in vaccine delivery worldwide! I was honoured to participate in the news of this great advance! #OakvilleNorth-#BurlON
Rapid Dose Therapeutics and McMaster University Provide Update on COVID-19 Vaccine Research Collaboration with Orally Dissolvable QuickStrip™ Technology. @mcmasterU@NRC_CNRC@NSERC_CRSNG#COVID19#Research
https://t.co/8ykYOBkBgA
PRESS RELEASE: RDT enters into a binding LOI for the acquisition of 2544737 Ontario Limited, operating as Consolidated Craft Brands in a share transaction totaling $5,000,000.00CDN. Read Full Release Here: https://t.co/WCSBp4yDkE
#QuickStrip $ Dose #cannabis#nutraceuticals
RDT is pleased to announce an Agreement with Perennial Brands, a DCM company, for the distribution and sale of nutraceutical oral dissolvable strip products in Canada, US and India
Read the full release here https://t.co/LwENrHG7eb
#QuickStrip#nutraceuticals#rapiddose $DOSE
Rapid Dose Therapeutics Receives Funding for Scale-Up Manufacturing and Commercialization of Quickstrip™ Product https://t.co/I7GOayVoYc @RapidDose#cannabisindustry
PRESS RELEASE: Rapid Dose Therapeutics Receives Funding for Scale-Up Manufacturing and Commercialization of Quickstrip™ Product
Read the full release here
https://t.co/SufPAPxVwr
#cannabisindustry#QuickStrip#RapidDose $DOSE